• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    More On RVXCF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Resverlogix Corp. (RVXCF)

    -Other OTC
    2.22 Down 0.03(1.49%) Apr 24, 3:16PM EDT
    Add to Portfolio
    Prev Close:2.25
    Open:2.17
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:2.17 - 2.30
    52wk Range:0.35 - 2.49
    Volume:13,700
    Avg Vol (3m):26,484
    Market Cap:N/A
    P/E (ttm):92.35
    EPS (ttm):0.02
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RVXCF

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Resverlogix Corp., a clinical stage biotechnology company, develops small molecules that selectively inhibit Bromodomain and ExtraTerminal domain proteins for high risk vascular diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback